Your session is about to expire
← Back to Search
Virtual Reality Therapy for Cerebral Palsy (HABIT-VR Trial)
N/A
Waitlist Available
Led By James E Gehringer, PhD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 1 week before the camp
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing two types of therapy camps for children with one-sided cerebral palsy. One camp uses virtual reality games to help improve hand and arm movements, while the other uses traditional physical activities. Both methods aim to make kids use their weaker hand more, helping to improve its strength and coordination. Virtual reality (VR) is a relatively new and innovative approach to facilitate hand function in children with cerebral palsy.
Who is the study for?
This trial is for children diagnosed with hemiplegic cerebral palsy (HCP) who can follow a two-week therapy program. They must have certain levels of manual ability but not have other neurological conditions, visual impairments, or musculoskeletal issues that would interfere with the therapy.
What is being tested?
The study compares two types of therapies: Standard Hand-Arm Bimanual Intensive Therapy (HABIT) and a virtual reality version called HABIT-VR. Each child will receive 40 hours of treatment over two weeks to improve hand function and coordination.
What are the potential side effects?
Since this is a physical and occupational therapy-based intervention involving virtual reality, side effects may include fatigue or discomfort from repetitive movements. VR-related side effects could include dizziness or nausea.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 1 week before the camp
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 1 week before the camp
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
9-Hole Peg Test Score
Assisting Hand Assessment Score
Box and Blocks Score
Secondary study objectives
Galvanic Skin Response
Heart Rate
Skin Temperature
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: HABIT-VRExperimental Treatment1 Intervention
Children will receive hand arm bimanual intensive therapy, however, it will be through the use of custom virtual reality games. Children will receive 40 hrs of one-on-one bimanual therapy, delivered through the virtual reality games. Activities will be self-selected, but all games have a task constraint, requiring both hands to succeed.
Group II: Standard HABITActive Control1 Intervention
Children will receive hand arm bimanual intensive therapy the way it is typically delivered. Children will receive 40 hrs of one-on-one bimanual therapy, delivered as play. Activities will be self-selected, but all options will require both hands to succeed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HABIT-VR
2022
N/A
~20
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Cerebral Palsy (CP) that aim to improve motor function, coordination, and hand use include intensive therapies like Hand-Arm Bimanual Intensive Therapy (HABIT) and its VR-based variant, HABIT-VR. These therapies work by providing repetitive, task-specific practice and sensory feedback, which enhance neuroplasticity and motor learning.
VR-based therapies offer an engaging, interactive environment that can make exercises more effective by providing real-time feedback and immersive tasks. This is important for CP patients as it can lead to significant improvements in motor planning, execution, and bimanual coordination, thereby enhancing their daily functioning and independence.
HABIT+tDCS: a study protocol of a randomised controlled trial (RCT) investigating the synergistic efficacy of hand-arm bimanual intensive therapy (HABIT) plus targeted non-invasive brain stimulation to improve upper extremity function in school-age children with unilateral cerebral palsy.Hand-arm bimanual intensive therapy and daily functioning of children with bilateral cerebral palsy: a randomized controlled trial.Effectiveness of Hand-Arm Bimanual Intensive Therapy on Hand Function among Children with Unilateral Spastic Cerebral Palsy: A Meta-Analysis.
HABIT+tDCS: a study protocol of a randomised controlled trial (RCT) investigating the synergistic efficacy of hand-arm bimanual intensive therapy (HABIT) plus targeted non-invasive brain stimulation to improve upper extremity function in school-age children with unilateral cerebral palsy.Hand-arm bimanual intensive therapy and daily functioning of children with bilateral cerebral palsy: a randomized controlled trial.Effectiveness of Hand-Arm Bimanual Intensive Therapy on Hand Function among Children with Unilateral Spastic Cerebral Palsy: A Meta-Analysis.
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
555 Previous Clinical Trials
1,145,368 Total Patients Enrolled
3 Trials studying Cerebral Palsy
1,074 Patients Enrolled for Cerebral Palsy
James E Gehringer, PhDPrincipal InvestigatorUniversity of Nebraska
1 Previous Clinical Trials
1 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child is visually impaired or blind.My child has a neurological condition affecting their ability to move their arms.My child has a condition affecting their ability to follow objects with their eyes.My parents agree to and will follow the study's requirements.My child has been diagnosed with HCP.My child can use their hands but with varying levels of difficulty.My child has a physical deformity that affects their ability to handle objects.
Research Study Groups:
This trial has the following groups:- Group 1: HABIT-VR
- Group 2: Standard HABIT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.